🔎 Trials Near Me

Home › Blood Disorders › California

Blood Disorders clinical trials in California

16 studies for Blood Disorders are looking for participants at sites in California.

Cities in California

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 1, Duarte
  • Quetzal Site 7, Los Angeles
  • Quetzal Site 5, Stanford
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Sep 23, 2026 · NCT07504458

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCLA Medical Center, Los Angeles
  • Stanford Cancer Institute, Stanford
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

  • University of Southern California, Los Angeles
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 11, 2026 · NCT07059000

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

  • City of Hope, Duarte
  • Stanford University, Palo Alto
  • UCSF, San Francisco
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07075185

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  • Pacific Cancer Medical Center, Inc, Anaheim
  • TOI Clinical Research, Cerritos
  • Stanford School of Medicine-Cancer Clinical Trials Office, Palo Alto
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05254743

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Orthopaedic Institute for Children HTC, Los Angeles
  • Childrens Hospital Los Angeles, Los Angeles
  • UCSF Benioff Children's Hospital Oakland, Oakland
  • and 5 more
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • UCLA Department of Medicine, Los Angeles
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT07216443

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Keck School of Medicine of USC, Los Angeles
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT04256317

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

  • USC / Norris Comprehensive Cancer Center, Los Angeles
RecruitingObservational studyHealthy volunteers welcome
Ages 19 and older · All sexes · Updated Apr 2, 2026 · NCT03207854

Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback

  • Lucile Packard Children's Hospital, Palo Alto
RecruitingPhase 1
1 Month – 45 Years · All sexes · Updated Jan 8, 2026 · NCT04640987

Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults

  • Lucile Packard Children's Hospital, Palo Alto
Recruiting
1 Month – 60 Years · All sexes · Updated May 29, 2025 · NCT04249830

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

  • LabPMM, San Diego
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 4, 2025 · NCT06222164

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

  • UC Davis Health, Sacramento
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 13, 2025 · NCT05423691

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.